Search
Now showing items 1-10 of 23
Evaluation of the risk factors for BK virus-associated hemorrhagic cystitis in pediatric bone marrow transplantation patients: Does post-transplantation cyclophosphamide increase the frequency?
(2022)
Background: BKV-HC is one of the most significant complications of HSCT. This ret -rospective study aimed to determine the frequency of BKV-HC in pediatric patients undergoing HSCT, detect the ...
The effect of biofilm inhibitor N-acetylcysteine on the minimum inhibitory concentration of antibiotics used in Gram-negative bacteria in the biofilm developed on catheters
(2022)
The study determined the effect of N-acetylcysteine (NAC) on the susceptibility of various antibiotics used to treat Gram-negative catheter-related infection in isolates obtained from pediatric patients admitted to the ...
Busulfan–fudarabine‑ or treosulfan–fudarabine‑based myeloablative conditioning for children with thalassemia major
(Annals of Hematology, 2021)
Signifcant advances in supportive care for patients with transfusion-dependent thalassemia major (TDT) have improved
patients’ life expectancy. However, transfusion-associated iron overload remains a signifcant barrier ...
Central nervous system fungal infections in children with leukemia and undergoing hematopoietic stem cell transplantation: A retrospective multicenter study
(2022)
Background: Central nervous system fungal infections (CNSFI) are seen in patients with hematologic malignancies and have high morbidity and mortality. Because of their rarity, there is limited data on CNSFI in children ...
Thalassemia-free and graft-versus-host-free survival: Outcomes of hematopoietic stem cell transplantation for thalassemia major, Turkish experience
(Bone Marrow Transplantation, 2022)
We report the national data on the outcomes of hematopoietic stem cell transplantation (HSCT) for thalassemia major (TM) patients
in Turkey on behalf of the Turkish Pediatric Stem Cell Transplantation Group. We retrospectively ...
Comparison of hematopoietic stem cell transplantation results in patients with beta-thalassemia major from three different graft types
(Taylor & Francis Ltd, 2021)
Allogeneic hematopoietic stem cell transplantation (HSCT) is the curative therapy for beta-thalassemias that induces severe life-threatening complications. The human leukocyte antigen (HLA) registries and umbilical cord ...
Prognostic factors for survival in children who relapsed after allogeneic hematopoietic stem cell transplantation for acute leukemia
(Wiley, 2021)
Background Post-transplant relapse has a dismal prognosis in children with acute leukemia undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). Data on risk factors, treatment options, and outcomes are ...
Stem cell transplantation for high-risk acute lymphoblastic leukemia in a developing country: A single-center experience
(Wiley, 2020)
[No abstract available]
Donor lymphocyte infusion administrations after allogeneic stem cell transplantations in pediatrics: A single center experience
(Nature Publishing Group, 2019)
Allogeneic stem cell transplantation (allo-SCT) is considered the cornerstone in the treatment of several malignant and not malignant hematological diseases. However, relapse of hematological disease after allo-SCT is ...
Immune reconstitution of thalassemia major patients after 1 year of hematopoetic stem cell transplantation
(Nature Publishing Group, 2019)
Immune reconstitution inflammatory syndrome (IRIS) is a clinical condition emerging after immune recovery of an immunocompromised status, mostly in human immunodeficiency virus infected patients but also in several other ...